SCCS - Scientific Opinion on Cannabidiol (CBD) (CAS/EC No. 13956-29- 1/ 689-176-3) used in cosmetic products

SCCS members: U. Bernauer, L. Bodin (Rapporteur), Q. Chaudhry, P.J. Coenraads (Chairperson), J. Ezendam, E. Gaffet, C. L. Galli, E. Panteri, V. Rogiers, Ch. Rousselle, M. Stepnik, T. Vanhaecke, S. Wijnhoven
SCCS external experts: E. Benfenati, N. Cabaton, E. Corsini, Ch. Delmaar, A. Koutsodimou, H. Louro, W. Uter, N. von Goetz 
Contact: SANTE-SCCSec [dot] europa [dot] eu (SANTE-SCCS[at]ec[dot]europa[dot]eu)
On request from: European Commission
SCCS Number: SCCS/1685/25
Adopted on: 30 October 2025

Conclusion of the opinion:

1. Taking under consideration the information/data submitted via the respective call for data, the SCCS is requested:

(a) to assess the maximum concentration of Cannabidiol that is considered safe when used in cosmetic products

In view of all the available data, the SCCS considers CBD safe when used at concentrations up to 0.19% in dermal cosmetic products and oral cosmetic products – whether used alone or together.

(b) to identify the maximum safe level of Delta- 9-tetrahydrocannabinol (THC) present as a contaminant in Cannabidiol preparations

The SCCS considers the presence of THC impurities as safe at concentrations up to 0.00025% in dermal and oral cosmetic products – whether used alone or together.

2. Does the SCCS have any further scientific concerns with regard to the use of CBD and the possible non-intended presence at trace levels of other cannabinoids, including THC, in cosmetic products?

This Opinion does not consider cosmetic products that may lead to exposure of the end-user's lungs by inhalation.

Keywords:

SCCS, scientific opinion, Cannabidiol, CBD, CAS No. 13956-29- 1, EC 689-176-3, Regulation 1223/2009

Opinion to be cited as:

SCCS (Scientific Committee on Consumer Safety), Scientific Opinion on Cannabidiol (CBD) (CAS/EC No. 13956-29- 1/ 689-176-3) used in cosmetic products, preliminary version of 30 October 2025, SCCS/1685/25.